H.C. Wainwright Reiterates Buy Rating on Harrow Health (HROW)
Tweet Send to a Friend
H.C. Wainwright analyst Yi Chen reiterated a Buy rating and $57.00 price target on Harrow Health (NASDAQ: HROW).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


